North America Infectious Diagnostics Market Outlook to 2024

Publisher Name :
Date: 01-Dec-2017
No. of pages: 596

North America Infectious Diagnostics Market Outlook to 2024

Summary

GlobalData's new report, North America Infectious Diagnostics Market Outlook to 2024, provides key market data on the North America Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology, Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Infectious Diagnostics market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests, Infectious Diagnostics Multiple Parameter Test Kits, Infectious Diagnostics Rapid Tests & POC, Mycobacterium tuberculosis Diagnostic Tests, Nucleic Acid Testing Extraction Instruments, Other Virology, Parasitology & Mycology Polymerase Chain Reaction (PCR) Systems, Post Streptococcus pyogenes Diagnostic Tests, Retrovirus Tests and Treponema pallidum Diagnostic Tests.

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.

- 2017 company shares and distribution shares data for each of the market segments.

- Global corporate-level profiles of key companies operating within the North America Infectious Diagnostics market.

- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Hologic Inc and Siemens Healthcare GmbH.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

North America Infectious Diagnostics Market Outlook to 2024

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 8
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Infectious Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 15
3 Infectious Diagnostics Market, North America 20
3.1 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2024 20
3.2 Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), 2010-2024 22
3.3 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2017 24
3.4 Infectious Diagnostics Market, North America, Revenue ($m), 2017-2024 27
3.5 Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 30
3.6 Infectious Diagnostics Market, North America, Volume (Units), 2010-2017 32
3.7 Infectious Diagnostics Market, North America, Volume (Units), 2017-2024 35
3.8 Infectious Diagnostics Market, North America, Company Share by Revenue ($m), 2017 38
4 Infectious Diagnostics Market, Canada 40
4.1 Infectious Diagnostics Market, Canada, Revenue ($m), 2010-2017 40
4.2 Infectious Diagnostics Market, Canada, Revenue ($m), 2017-2024 43
4.3 Infectious Diagnostics Market, Canada, Volume (Units), 2010-2017 90
4.4 Infectious Diagnostics Market, Canada, Volume (Units), 2017-2024 93
4.5 Infectious Diagnostics Market, Canada, Average Price ($), 2010-2024 142
4.6 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 150
4.7 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2017 151
5 Infectious Diagnostics Market, Mexico 153
5.1 Infectious Diagnostics Market, Mexico, Revenue ($m), 2010-2017 153
5.2 Infectious Diagnostics Market, Mexico, Revenue ($m), 2017-2024 156
5.3 Infectious Diagnostics Market, Mexico, Volume (Units), 2010-2017 203
5.4 Infectious Diagnostics Market, Mexico, Volume (Units), 2017-2024 206
5.5 Infectious Diagnostics Market, Mexico, Average Price ($), 2010-2024 255
5.6 Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2017 261
5.7 Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2017 262
6 Infectious Diagnostics Market, United States 264
6.1 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 264
6.2 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 267
6.3 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 314
6.4 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 317
6.5 Infectious Diagnostics Market, United States, Average Price ($), 2010-2024 366
6.6 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 373
6.7 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 374
7 Overview of Key Companies in North America Infectious Diagnostics Market 376
7.1 Abbott Laboratories 376
7.2 F. Hoffmann-La Roche Ltd 376
7.3 Hologic Inc 376
7.4 Qiagen NV 377
7.5 Siemens Healthcare GmbH 377
7.6 Alere Inc 377
7.7 Beckman Coulter Inc 377
7.8 Bio-Rad Laboratories Inc 378
7.9 Becton Dickinson and Co 378
7.10 Cepheid 378
7.11 DiaSorin S.p.A 378
7.12 bioMerieux SA 379
7.13 Thermo Fisher Scientific Inc 379
8 Infectious Diagnostics Market Pipeline Products 380
9 Recent Developments 392
9.1 Corporate Communications 392
9.2 Financial Announcements 419
9.3 Government and Public Interest 546
9.4 Legal And Regulatory 549
9.5 Other Significant Developments 555
9.6 Product News 566
9.7 Strategy And Business Planning 578
10 Appendix 580
10.1 Research Methodology 581
10.2 GlobalData Consulting 585
10.3 Contact Us 586
10.4 Disclaimer 586

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 31
Table 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 33
Table 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 35
Table 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 38
Table 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 41
Table 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 43
Table 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 46
Table 8: Infectious Diagnostics Market, North America, Company Share by Revenue ($m), USD Constant, 2017 49
Table 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 51
Table 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 57
Table 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 59
Table 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 61
Table 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 63
Table 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 65
Table 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 67
Table 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 69
Table 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 71
Table 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 73
Table 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 75
Table 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 77
Table 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 79
Table 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 81
Table 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 83
Table 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 85
Table 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 87
Table 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 89
Table 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 91
Table 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 93
Table 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 95
Table 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 97
Table 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 99
Table 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 101
Table 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 104
Table 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 107
Table 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 109
Table 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 111
Table 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 113
Table 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 115
Table 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 117
Table 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 119
Table 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 121
Table 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 123
Table 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 125
Table 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 127
Table 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 130
Table 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 132
Table 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 134
Table 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 136
Table 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 138
Table 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 140
Table 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 142
Table 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 144
Table 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 146
Table 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 148
Table 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 150
Table 57: Infectious Diagnostics Market, Canada, Average Price ($) Historic, 2010-2017 152
Table 58: Infectious Diagnostics Market, Canada, Average Price ($), Forecast, 2017-2024 156
Table 59: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 160
Table 60: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 162
Table 61: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 164
Table 62: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Table 63: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 170
Table 64: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 172
Table 65: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 174
Table 66: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 176
Table 67: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 178
Table 68: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 180
Table 69: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 182
Table 70: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 184
Table 71: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 186
Table 72: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 188
Table 73: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 190
Table 74: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 192
Table 75: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 194
Table 76: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 196
Table 77: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 198
Table 78: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 200
Table 79: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 202
Table 80: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 204
Table 81: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 206
Table 82: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 208
Table 83: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 210
Table 84: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 85: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 214
Table 86: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 217
Table 87: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 220
Table 88: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 222
Table 89: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 224
Table 90: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 226
Table 91: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 228
Table 92: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 230
Table 93: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 232
Table 94: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Historic, 2010-2017 234
Table 95: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 236
Table 96: Retrovirus Tests Market, Mexico, Volume (Units), Historic, 2010-2017 238
Table 97: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 240
Table 98: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 243
Table 99: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 245
Table 100: Hepatitis Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 247
Table 101: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 249
Table 102: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 251
Table 103: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 253
Table 104: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 255
Table 105: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Forecast, 2017-2024 257
Table 106: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 259
Table 107: Retrovirus Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 261
Table 108: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 263
Table 109: Infectious Diagnostics Market, Mexico, Average Price ($) Historic, 2010-2017 265
Table 110: Infectious Diagnostics Market, Mexico, Average Price ($), Forecast, 2017-2024 268
Table 111: Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 271
Table 112: Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 273
Table 113: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 275
Table 114: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 278
Table 115: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 281
Table 116: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 283
Table 117: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 285
Table 118: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 287
Table 119: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 289
Table 120: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 291
Table 121: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 293
Table 122: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 295
Table 123: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 297
Table 124: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 299
Table 125: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 301
Table 126: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 303
Table 127: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 305
Table 128: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 307
Table 129: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 309
Table 130: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 311
Table 131: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 313
Table 132: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 315
Table 133: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 317
Table 134: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 319
Table 135: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 321
Table 136: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 323
Table 137: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 325
Table 138: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 328
Table 139: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 331
Table 140: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 333
Table 141: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 335
Table 142: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 337
Table 143: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 339
Table 144: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 341
Table 145: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 343
Table 146: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 345
Table 147: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 347
Table 148: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 349
Table 149: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 351
Table 150: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 354
Table 151: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 356
Table 152: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 358
Table 153: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 360
Table 154: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 362
Table 155: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 364
Table 156: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 366
Table 157: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 368
Table 158: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 370
Table 159: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 372
Table 160: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 374
Table 161: Infectious Diagnostics Market, United States, Average Price ($) Historic, 2010-2017 376
Table 162: Infectious Diagnostics Market, United States, Average Price ($), Forecast, 2017-2024 380
Table 163: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 383
Table 164: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 385
Table 165: Infectious Diagnostics Market Pipeline Products 390
Table 166: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 593

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 30
Figure 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 32
Figure 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 34
Figure 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 37
Figure 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 40
Figure 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 42
Figure 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 45
Figure 8: Infectious Diagnostics Market, North America, Company Share (%) 2017 48
Figure 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 50
Figure 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 56
Figure 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 58
Figure 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 60
Figure 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 62
Figure 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 64
Figure 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 66
Figure 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 68
Figure 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 70
Figure 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 78
Figure 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 80
Figure 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 82
Figure 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 84
Figure 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 86
Figure 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 100
Figure 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 103
Figure 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 106
Figure 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 108
Figure 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 110
Figure 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 112
Figure 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 114
Figure 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 116
Figure 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 118
Figure 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 120
Figure 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 122
Figure 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 124
Figure 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 126
Figure 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 129
Figure 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 131
Figure 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 133
Figure 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 135
Figure 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 137
Figure 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 139
Figure 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 141
Figure 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 143
Figure 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 145
Figure 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 147
Figure 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 149
Figure 57: Infectious Diagnostics Market, Canada, Company Share (%) 2017 161
Figure 58: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 163
Figure 59: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Figure 60: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 169
Figure 61: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 171
Figure 62: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 173
Figure 63: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 175
Figure 64: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 177
Figure 65: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 179
Figure 66: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 181
Figure 67: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 183
Figure 68: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 185
Figure 69: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 187
Figure 70: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 189
Figure 71: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 191
Figure 72: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 193
Figure 73: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 195
Figure 74: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 197
Figure 75: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Figure 76: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Figure 77: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 203
Figure 78: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Figure 79: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Figure 80: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Figure 81: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 82: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 213
Figure 83: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 216
Figure 84: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 219
Figure 85: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 221
Figure 86: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 223
Figure 87: Human Papilloma Virus
  • Global Influenza Diagnostics Market Research Report 2017
    Published: 12-Dec-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Influenza Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Influenza Diagnostics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • EU5 Infectious Diagnostics Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 764
    EU5 Infectious Diagnostics Market Outlook to 2024 Summary GlobalData's new report, EU5 Infectious Diagnostics Market Outlook to 2024, provides key market data on the EU5 Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papillom......
  • Asia-Pacific Infectious Diagnostics Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 625
    Asia-Pacific Infectious Diagnostics Market Outlook to 2024 Summary GlobalData's new report, Asia-Pacific Infectious Diagnostics Market Outlook to 2024, provides key market data on the Asia-Pacific Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatiti......
  • BRIC Infectious Diagnostics Market Outlook to 2024
    Published: 01-Dec-2017        Price: US 5995 Onwards        Pages: 504
    BRIC Infectious Diagnostics Market Outlook to 2024 Summary GlobalData's new report, BRIC Infectious Diagnostics Market Outlook to 2024, provides key market data on the BRIC Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Bacteriology, Chlamydia trichomatis Diagnostic Test Kits, Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests, Hepatitis Test Kits, Human Papil......
  • Global POC Diagnostics Market Size, Status and Forecast 2022
    Published: 22-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global POC Diagnostics market, analyzes and researches the POC Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Alere - Roche - Abbott Laboratories - Johnson & Johnson - Siemens Healthcare - Danaher - Bayer Healthcare - Beckman Coulter - Nipro Diagnostics - Bio-Rad Laboratories......
  • Point-ofCare Diagnostics Market 2021: Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Test Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 12500 Onwards        Pages: 0
    This new 1,007-page report from VPGMarketResearch.com contains 180 tables, provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies.RationaleThe ......
  • Point-of-Care Infectious Disease Market 2021: Physician Offices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers--Supplier Shares, Test Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 5500 Onwards        Pages: 0
    This new 795-page report from VPGMarketResearch.com contains 61 tables, and provides a comprehensive analysis of thePOC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.......
  • Drugs of Abuse Diagnostics Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 318-page report from VPGMarketResearch.com contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment ......
  • France Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualon......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs